Hyperlipemia

11 registered clinical trials studyying Hyperlipemia.

Status	Trial	Sponsor	Phase
Completed	A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of S NCT06229548	CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.	Phase 1
Completed	A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD70 NCT05912296	Suzhou Ribo Life Science Co. Ltd.	Phase 1
Unknown	Safety and Tolerability of SHR-1918 in Healthy Subjects NCT05432544	Beijing Suncadia Pharmaceuticals Co., Ltd	Phase 1
Completed	The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipid NCT05532800	Shanghai Junshi Bioscience Co., Ltd.	Phase 3
Completed	The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia NCT04781114	Shanghai Junshi Bioscience Co., Ltd.	Phase 3
Completed	A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions NCT04382521	Massachusetts General Hospital	N/A
Completed	To Evaluate the Efficacy and Safety of JS002 in HoFH Patients NCT04515927	Shanghai Junshi Bioscience Co., Ltd.	Phase 2
Completed	Effect of Consumption of Bagel Without Palm Oil on Postprandial Lipidemia NCT03950752	Technological Centre of Nutrition and Health, Spain	N/A
Completed	A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlip NCT04469673	Shanghai Junshi Bioscience Co., Ltd.	Phase 1 / Phase 2
Completed	Veteran Peer Coaches Optimizing and Advancing Cardiac Health NCT02697422	VA Office of Research and Development	N/A
Unknown	Effect of Rosuvastatin Therapy on HDL2 Level NCT02593487	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	Phase 4